A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials
Authors:
Open Access
- 19 July 2023
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 149 (14) , 12897-12902
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Federal Ministry of Education and Research (BMBF O1KD 1906)
- Universitätsklinikum Würzburg
This publication has 11 references indexed in Scilit:
- Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaNew England Journal of Medicine, 2022
- Preferences and Priorities for Relapsed Multiple Myeloma Treatments Among Patients and Caregivers in the United StatesPatient Preference and Adherence, 2022
- Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From GermanyClinical Lymphoma Myeloma and Leukemia, 2021
- European Society for Medical Oncology (ESMO) position paper on supportive and palliative careAnnals of Oncology, 2017
- Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-AnalysisJournal of Clinical Oncology, 2017
- Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialThe Lancet Haematology, 2017
- Patient involvement in clinical research: why, when, and howPatient Preference and Adherence, 2016
- Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatmentBlood, 2014
- Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European, multicenter cohort studySupportive Care in Cancer, 2013
- Health‐related quality of life and disease‐specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population‐based study using the PROFILES registryEuropean Journal of Haematology, 2012